Inventor · disambiguated record
Ruin Moaddel
Also filed as: MOADDEL RUIN
7 granted patents·8 pending applications·46 citations·filing 2002–2025
82Inventor score
Top patents by PatentIndex Score
15 records- 0192US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0292US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0390US11613514B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2021·Granted Mar 28, 2023·2 cites·15 claims
- 0489US10919842B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 0577US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0675US12473251B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2023·Granted Nov 18, 2025·0 cites·3 claims
- 0775US2024374550A1Gingerenone a prodrugs and methods of useUS HEALTH·Filed 2024·Application pending·0 cites
- 0870US12325688B2Gingerenone A prodrugs as sensotherapeutics and methods of useUS HEALTH·Filed 2023·Granted Jun 10, 2025·0 cites·13 claims
- 0968US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1063US7749984B2Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptorsUS HEALTH·Filed 2004·Granted Jul 6, 2010·1 cites·5 claims
- 1159US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
- 1241US2019083420A1Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disordersUS HEALTH·Filed 2017·Application pending·0 cites
- 1341US2003150812A1Novel parallel throughput systemFiled 2002·Application pending·0 cites
- 1438US2003166301A1Multiple binding moiety chromatography device, methods of using and methods of making sameFiled 2002·Application pending·0 cites
- 1533US2003006192A1Immobilized G-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screeningFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ruin Moaddel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →